Form 4: Viatris Inc. Executive Receives Stock Grants

Corinne Le Goff, Chief Commercial Officer of Viatris Inc., reports the acquisition of restricted stock units (RSUs) on April 18, 2024.

Summary

• On April 18, 2024, Corinne Le Goff, Chief Commercial Officer of Viatris Inc., acquired 78,688 and 110,162 restricted stock units (RSUs).
• The RSUs represent the right to receive one share of Viatris common stock each.
• 78,688 RSUs vest in two equal annual installments beginning on April 15, 2025.
• 36,721 of the 110,162 RSUs will vest on March 4, 2025, 36,720 will vest on March 4, 2026, and 36,721 will vest on March 4, 2027.
• Following the transaction, Le Goff directly owns 78,688 and 110,162 RSUs.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of stock grants, which is neither particularly positive nor negative. It reflects standard executive compensation practices.

Positives

• The grant of RSUs to the Chief Commercial Officer aligns her interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The vesting of the RSUs is contingent upon continued employment and will result in the issuance of Viatris common stock over the vesting period.

Industry Context

Stock grants are a common form of executive compensation in the pharmaceutical industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Comparing Viatris's executive compensation structure to peers like Teva Pharmaceuticals or Mylan (prior to the merger) would provide a benchmark for assessing the competitiveness and appropriateness of these grants.
• Industry standards often involve a mix of salary, bonus, and equity-based compensation, with the proportion of each varying based on company size, performance, and strategic goals.
• Vesting schedules are also a common feature, designed to incentivize long-term value creation.

Stakeholder Impact

• The stock grants could potentially impact shareholders by diluting equity if new shares are issued upon vesting.
• Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates